Eric Topol has been appointed to the scientific advisory board of Perlegen. He is chief academic officer of The Cleveland Clinic Foundation and provost of the Cleveland Clinic Lerner College of Medicine of Case Western University.
Michael Stapleton has become general manager and vice president, and Vivien Bonazzi director of research and development at Invitrogen’s bioinformatics business. Stapleton previously worked at Accelrys, where he was executive vice president and COO. He holds a doctorate and master’s degrees in chemical physics, and a bachelor’s degree in chemistry from Southampton University in the UK.
Bonazzi joins Invitrogen from Celera Genomics, where she was director of product development and scientific management.
Clive Seymour has become vice president for Asia-Pacific at Bruker BioSciences. Seymour was previously vice president for the Asia-Pacific region at Biacore. Prior to that, he was vice president corporate communications and head of life science research business unit at Biacore. He has also been European market area manager for Pharmacia Biotech Europe, and regional marketing and sales manager for Pharmacia Biotech Asia-Pacific.